What allegations of Alzheimer's research fraud mean for patients
- Written by: John Mamo, John Curtin Distinguished Professor of Health Sciences, Director, Curtin Health Innovation Research Institute, Curtin University
Alzheimer’s disease is the most prevalent form of dementia and, with a rapidly ageing global population, it is fuelling unprecedented demand for costly patient care. There have been an estimated 400 clinical studies since the first Alzheimer’s drug trial in 1987.
The demand for treatment solutions however, is not without significant...
Read more: What allegations of Alzheimer's research fraud mean for patients
